Dihexa

Dihexa promotes synaptogenesis and enhances synaptic density, demonstrating potent neurotrophic activity in preclinical models, up to seven orders of magnitude greater than brain-derived neurotrophic factor (BDNF).¹,²,³ In animal models of Alzheimer's disease, it restores spatial learning and cognitive functions, reduces neuroinflammation by decreasing astrocyte and microglia activation, and ameliorates neuronal loss.²,⁴,⁵ These effects position Dihexa as an investigational agent for neurodegenerative conditions, including potential support in Parkinson's disease and traumatic brain injury recovery, though human clinical trials remain lacking.¹,⁴,⁶ Short-term safety studies indicate no apparent toxicity or neoplastic induction.³

Dihexa's reported side effects are generally mild and include headaches, fatigue, gastrointestinal discomfort, sleep disturbances such as vivid dreams or insomnia, irritability, anxiety, and overstimulation, often transient during initial use.²,⁴,⁷,⁸,⁹ Rare potential effects encompass bleeding problems with symptoms like bruising or nosebleeds, and allergic reactions including rash, hives, or swelling.² Key safety considerations involve a profound lack of human clinical trials and long-term data, with most information derived from preclinical animal studies and anecdotal reports, necessitating medical supervision.²,⁴,⁶,⁸ Theoretical risks stem from its activation of the HGF/c-Met pathway, which could promote tumorigenesis or cancer progression, making it contraindicated in patients with active malignancy or high cancer risk.⁴,⁶,⁹ Additional cautions apply to pregnancy, breastfeeding, and concurrent use with other neuroactive compounds due to insufficient data and potential interactions.⁴,⁸ Its long half-life further underscores the need for caution regarding accumulation.⁶

Dihexa binds with high affinity to hepatocyte growth factor (HGF) and potentiates its activity at the c-Met receptor, thereby activating the HGF/c-Met signaling pathway.³,⁴,⁶,¹⁰ This activation promotes synaptogenesis, dendritic spine formation, and enhanced synaptic plasticity by stimulating neuronal growth and connectivity.⁴,⁷,¹¹ Dihexa also engages the PI3K/AKT signaling pathway, which contributes to its anti-inflammatory, anti-apoptotic, and neurotrophic effects, including increased neuronal cell counts and reduced pro-inflammatory cytokines.⁵,¹⁰ These mechanisms support neuroprotection and cognitive enhancement, with activity reported as seven times greater than brain-derived neurotrophic factor (BDNF).¹⁰